Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance-Reference-Cited by-同舟云学术

Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance

Published:2016-05-10 Issue:6 Volume:16 Page:615-623
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Russo Alessandro,Franchina Tindara,Ricciardi Giuseppina Rosaria Rita,Ferraro Giuseppa,Scimone Antonino,Bronte Giuseppe,Russo Antonio,Rolfo Christian,Adamo Vincenzo

Funder

Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO).

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/14737140.2016.1182427

Reference97 articles.

1. Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy

2. Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases

3. Incidence of brain metastasis at initial presentation of lung cancer

4. Current approaches to the treatment of metastatic brain tumours

5. Unsanctifying the sanctuary: challenges and opportunities with brain metastases

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An updated patent review of anaplastic lymphoma kinase inhibitors (2018–2022);Expert Opinion on Therapeutic Patents;2023-04-03

2. Combination of Stereotactic Ablative Radiotherapy and Systemic Therapy in Oligoprogressive Non-small Cell Lung Cancer;Interdisciplinary Cancer Research;2023

3. Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib;Pulmonology;2022-12

4. Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers;JCO Precision Oncology;2022-10

5. Complete response to alectinib following crizotinib in an ALK-positive inflammatory myofibroblastic tumor with CNS involvement;Current Problems in Cancer: Case Reports;2021-12